Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Thousand Oaks Biopharma Closes $45 Million Series A Funding Round

publication date: Jan 3, 2019

Thousand Oaks Biopharma, a China-US CMC company that offers GMP cell culture media and biomanufacturing services, closed a $45 million Series A financing. It will use the proceeds to advance its CDMO operations and begin construction of Large Scale Cell Culture Media (LSCCM) cGMP Manufacturing facilities in Haimen, Nantong, part of greater Shanghai. The company has operations in Shanghai, Haimen, and Lanzhou, China; plus Thousand Oaks and Pleasanton, CA. The financing was led by New Alliance Capital. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital